Dachaigh › Aillse cealla dendritic plasmacytoid blastach
Sgrùdaidhean clionaigeach Aillse cealla dendritic plasmacytoid blastach a’ fastadh anns na SA
Tha 8 sgrùdaidhean airson Aillse cealla dendritic plasmacytoid blastach a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04216524Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
A’ fastadhÌre 2
6 Months – 65 Years · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06013423SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT03113643Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 5 Ògmh 2026 · NCT05430971CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04318678HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
A’ fastadhÌre 1
Suas gu aois 80 · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT03326921Q702 for the Treatment of Patients With Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Dàmh 2025 · NCT06712810Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.